Inhibin-Positive “Cholangioblastic” Variant of Intrahepatic Cholangiocarcinoma: Report of 3 New Patients With Review of the Literature
- 18 April 2023
- journal article
- review article
- Published by SAGE Publications in International Journal of Surgical Pathology
- Vol. 31 (8) , 1495-1504
Abstract
Cholangiocarcinoma is the second most common primary liver malignant neoplasm. It usually affects older individuals in their seventh decade of life with no gender predilection. Recently, a distinct subtype of cholangiocarcinoma has emerged with 2 proposed names: “cholangioblastic” and “solid tubulocystic.” This variant predominantly occurs in younger women who lack the common risk factors for patients diagnosed with cholangiocarcinomas, such as older age and chronic liver disease or cirrhosis. We describe 3 new patients with a cholangioblastic variant of intrahepatic cholangiocarcinoma. At the time of diagnosis, the patients were aged 19-, 46-, and 28-year-old; 2 females and 1 male (the 46-year-old). None of our patients had a history of chronic liver disease or known predisposing factors for liver tumors. Tumor size ranged from 2.3 to 23 cm in greatest dimension. Histological examination of these tumors demonstrated reproducible morphology characterized by trabecular, nested, and multicystic patterns with micro and macro follicles filled with eosinophilic material. The immunohistochemical profile showed that the tumor cells were positive for keratin 7, inhibin, synaptophysin, and albumin in situ hybridization, while negative for HepPar1, arginase, and INSM1. All tumors lacked conventional intrahepatic cholangiocarcinoma/adenocarcinoma morphology. We also review the literature and emphasize that neuroendocrine tumors should be recognized as a major diagnostic pitfall of this variant.Keywords
This publication has 27 references indexed in Scilit:
- Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the RiseThe Oncologist, 2016
- Branched Chain In Situ Hybridization for Albumin as a Marker of Hepatocellular DifferentiationAmerican Journal of Surgical Pathology, 2015
- Secular Trends in the Incidence of Cholangiocarcinoma in the USA and the Impact of MisclassificationDigestive Diseases and Sciences, 2014
- Inhibin-expressing clear cell neuroendocrine tumor of the ampulla: an unusual presentation of von Hippel–Lindau diseaseVirchows Archiv, 2013
- Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypesHepatology, 2012
- FOXL2 Is a Sensitive and Specific Marker for Sex Cord-Stromal Tumors of the OvaryAmerican Journal of Surgical Pathology, 2011
- Intrahepatic cholangiocarcinoma resembling a thyroid follicular neoplasmVirchows Archiv, 2010
- SF-1 is a Diagnostically Useful Immunohistochemical Marker and Comparable to Other Sex Cord-Stromal Tumor Markers for the Differential Diagnosis of Ovarian Sertoli Cell TumorInternational Journal of Gynecological Pathology, 2008
- Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell originHepatology, 2008
- Clear Cell Carcinoid Tumor of the GallbladderAmerican Journal of Surgical Pathology, 2001